Semaglutide 2.4mg Weekly Shows Promise for Adolescent Weight Management
A Research Study on How Well Semaglutide Works in Adolescents With Overweight or Obesity
Background
The global prevalence of obesity and overweight among adolescents is a growing public health crisis, contributing to significant long-term health complications. Despite the urgent need, effective and safe pharmacological interventions specifically tailored for this younger demographic remain limited. This randomized, placebo-controlled trial directly addresses this gap by investigating the efficacy and safety of semaglutide 2.4 mg once weekly in adolescents with overweight or obesity.